TransEnterix Revenue and Competitors

Claim your profile



Total Funding

Estimated Revenue & Valuation

  • TransEnterix's estimated annual revenue is currently $2.4M per year.(i)
  • TransEnterix received $40.0M in venture funding in May 2018.
  • TransEnterix's estimated revenue per employee is $9,796
  • TransEnterix's total funding is $427.9M.

Employee Data

  • TransEnterix has 245 Employees.(i)
  • TransEnterix grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

TransEnterix® Surgical, Inc. (NYSE:TRXC), headquartered in Morrisville, North Carolina, is advancing surgery through innovation®. Our vision is to improve clinical outcomes and patient care through the use of robotics in surgery. We are focused on the commercialization of the Senhance Surgical System. Senhance has been granted a CE Mark and is available for sale in the United States. For a complete list of indications for use, please visit:



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





TransEnterix News

2022-04-20 - Bariatric Surgical Devices Market Size, Scope And Outlook ...

... Johnson and Johnson, Aspire Bariatrics, GI Dynamics, TransEnterix, USGI Medical, Apollo Endosurgery, Olympus, Mediflex Surgical Product.

2022-04-19 - Gynecology Robotic Surgery Market Size, Outlook And ...

Intuitive Surgical, Titan Medical, TransEnterix, AVRA Surgical Robotics, NovaTract Surgical. This comprehensive Gynecology Robotic Surgery...

2021-02-23 - TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Feb 23, 2021-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will change its corporate name to A ...

2019-08-09 - TransEnterix shares dive on disappointing Q2 sales

Shares of TransEnterix (NYSE:TRXC) started inching back up this morning following a nearly 33% plunge yesterday fueled by disappointing second-quarter results. The Research Triangle Park, N.C.-based company posted losses of $20.1 million, or -10¢ per share, on sales of $3.64 million for the thr ...

2019-05-09 - TransEnterix prices stock offering; shares down 18%

TransEnterix (TRXC -17.6%) is down on below-average volume in response to its public offering of 28M common shares that it expects to ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

TransEnterix Funding

DateAmountRoundLead InvestorsReference
2009-10-08$55.0MBAisling CapitalArticle
2014-10-01$25.0MUndisclosedOxford FinanceArticle
2016-12-22$25.0MUndisclosedLincoln Park CapitalArticle
2017-01-09$5.2MUndisclosedSOFAR S.p.AArticle
2018-05-25$40.0MUndisclosedHercules Capital IncArticle